カテゴリ： 世界, IT/電子, QYResearch

イロプロスト医薬品の世界市場2023年：吸入式、静脈注射式

■ 英語タイトル：Global Iloprost Drugs Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8791）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8791
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：61
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[イロプロスト医薬品の世界市場2023年：吸入式、静脈注射式]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はイロプロスト医薬品のグローバル市場について調査・分析し、世界のイロプロスト医薬品市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（吸入式、静脈注射式）、用途別セグメント分析（病院、診療所）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Actelion (J & J)、Bayer AGなどが含まれています。イロプロスト医薬品のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、イロプロスト医薬品市場規模を算出する際に考慮しました。

・イロプロスト医薬品市場の概要
- イロプロスト医薬品の種類別セグメント
- 世界のイロプロスト医薬品市場規模：タイプ別分析（吸入式、静脈注射式）
- イロプロスト医薬品の用途別セグメント
- 世界のイロプロスト医薬品市場規模：用途別分析（病院、診療所）
- 世界のイロプロスト医薬品市場規模予測（2018年-2029年）

・イロプロスト医薬品市場の成長トレンド
- イロプロスト医薬品の地域別市場規模（2018年-2029年）
- イロプロスト医薬品市場ダイナミクス
- イロプロスト医薬品の業界動向
- イロプロスト医薬品市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：吸入式、静脈注射式
- 世界のイロプロスト医薬品のタイプ別市場規模（2018年-2023年）
- 世界のイロプロスト医薬品のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、診療所
- 世界のイロプロスト医薬品の用途別市場規模（2018年-2023年）
- 世界のイロプロスト医薬品の用途別市場規模（2024年-2029年）

・イロプロスト医薬品の地域別市場規模
- 北米のイロプロスト医薬品市場規模（2018年-2029年）
- 米国のイロプロスト医薬品市場規模（2018年-2029年）
- ヨーロッパのイロプロスト医薬品市場規模（2018年-2029年）
- アジア太平洋のイロプロスト医薬品市場規模（2018年-2029年）
- 中国のイロプロスト医薬品市場規模（2018年-2029年）
- 日本のイロプロスト医薬品市場規模（2018年-2029年）
- 韓国のイロプロスト医薬品市場規模（2018年-2029年）
- インドのイロプロスト医薬品市場規模（2018年-2029年）
- オーストラリアのイロプロスト医薬品市場規模（2018年-2029年）
- 中南米のイロプロスト医薬品市場規模（2018年-2029年）
- 中東・アフリカのイロプロスト医薬品市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Actelion (J & J)、Bayer AG

・アナリストの観点/結論

・調査手法と情報源

Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud’s phenomenon and other diseases in which the blood vessels are constricted and blood can’t flow to the tissues.
Highlights
The global Iloprost Drugs market was valued at US$ 88 million in 2022 and is anticipated to reach US$ 80 million by 2029, witnessing a CAGR of -1.6% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is estimated to have a major share in the global market with 75%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Iloprost Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iloprost Drugs.
The Iloprost Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Iloprost Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iloprost Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Actelion (J & J)
Bayer AG
Segment by Type
Inhaled
Intravenous
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Iloprost Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Iloprost Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Inhaled
1.2.3 Intravenous
1.3 Market by Application
1.3.1 Global Iloprost Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Iloprost Drugs Market Perspective (2018-2029)
2.2 Iloprost Drugs Growth Trends by Region
2.2.1 Global Iloprost Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Iloprost Drugs Historic Market Size by Region (2018-2023)
2.2.3 Iloprost Drugs Forecasted Market Size by Region (2024-2029)
2.3 Iloprost Drugs Market Dynamics
2.3.1 Iloprost Drugs Industry Trends
2.3.2 Iloprost Drugs Market Drivers
2.3.3 Iloprost Drugs Market Challenges
2.3.4 Iloprost Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Iloprost Drugs Players by Revenue
3.1.1 Global Top Iloprost Drugs Players by Revenue (2018-2023)
3.1.2 Global Iloprost Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Iloprost Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Iloprost Drugs Revenue
3.4 Global Iloprost Drugs Market Concentration Ratio
3.4.1 Global Iloprost Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Iloprost Drugs Revenue in 2022
3.5 Iloprost Drugs Key Players Head office and Area Served
3.6 Key Players Iloprost Drugs Product Solution and Service
3.7 Date of Enter into Iloprost Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Iloprost Drugs Breakdown Data by Type
4.1 Global Iloprost Drugs Historic Market Size by Type (2018-2023)
4.2 Global Iloprost Drugs Forecasted Market Size by Type (2024-2029)
5 Iloprost Drugs Breakdown Data by Application
5.1 Global Iloprost Drugs Historic Market Size by Application (2018-2023)
5.2 Global Iloprost Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Iloprost Drugs Market Size (2018-2029)
6.2 North America Iloprost Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Iloprost Drugs Market Size by Country (2018-2023)
6.4 North America Iloprost Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Iloprost Drugs Market Size (2018-2029)
7.2 Europe Iloprost Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Iloprost Drugs Market Size by Country (2018-2023)
7.4 Europe Iloprost Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Iloprost Drugs Market Size (2018-2029)
8.2 Asia-Pacific Iloprost Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Iloprost Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Iloprost Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Iloprost Drugs Market Size (2018-2029)
9.2 Latin America Iloprost Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Iloprost Drugs Market Size by Country (2018-2023)
9.4 Latin America Iloprost Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Iloprost Drugs Market Size (2018-2029)
10.2 Middle East & Africa Iloprost Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Iloprost Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Iloprost Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Actelion (J & J)
11.1.1 Actelion (J & J) Company Detail
11.1.2 Actelion (J & J) Business Overview
11.1.3 Actelion (J & J) Iloprost Drugs Introduction
11.1.4 Actelion (J & J) Revenue in Iloprost Drugs Business (2018-2023)
11.1.5 Actelion (J & J) Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Detail
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Iloprost Drugs Introduction
11.2.4 Bayer AG Revenue in Iloprost Drugs Business (2018-2023)
11.2.5 Bayer AG Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Iloprost Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Inhaled
Table 3. Key Players of Intravenous
Table 4. Global Iloprost Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Iloprost Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Iloprost Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Iloprost Drugs Market Share by Region (2018-2023)
Table 8. Global Iloprost Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Iloprost Drugs Market Share by Region (2024-2029)
Table 10. Iloprost Drugs Market Trends
Table 11. Iloprost Drugs Market Drivers
Table 12. Iloprost Drugs Market Challenges
Table 13. Iloprost Drugs Market Restraints
Table 14. Global Iloprost Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Iloprost Drugs Market Share by Players (2018-2023)
Table 16. Global Top Iloprost Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iloprost Drugs as of 2022)
Table 17. Ranking of Global Top Iloprost Drugs Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Iloprost Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Iloprost Drugs Product Solution and Service
Table 21. Date of Enter into Iloprost Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Iloprost Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Iloprost Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global Iloprost Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Iloprost Drugs Revenue Market Share by Type (2024-2029)
Table 27. Global Iloprost Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Iloprost Drugs Revenue Market Share by Application (2018-2023)
Table 29. Global Iloprost Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Iloprost Drugs Revenue Market Share by Application (2024-2029)
Table 31. North America Iloprost Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Iloprost Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Iloprost Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Iloprost Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Iloprost Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Iloprost Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Iloprost Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Iloprost Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Iloprost Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Iloprost Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Iloprost Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Iloprost Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Iloprost Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Iloprost Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Iloprost Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. Actelion (J & J) Company Detail
Table 47. Actelion (J & J) Business Overview
Table 48. Actelion (J & J) Iloprost Drugs Product
Table 49. Actelion (J & J) Revenue in Iloprost Drugs Business (2018-2023) & (US$ Million)
Table 50. Actelion (J & J) Recent Development
Table 51. Bayer AG Company Detail
Table 52. Bayer AG Business Overview
Table 53. Bayer AG Iloprost Drugs Product
Table 54. Bayer AG Revenue in Iloprost Drugs Business (2018-2023) & (US$ Million)
Table 55. Bayer AG Recent Development
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Iloprost Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Iloprost Drugs Market Share by Type: 2022 VS 2029
Figure 3. Inhaled Features
Figure 4. Intravenous Features
Figure 5. Global Iloprost Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Iloprost Drugs Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Iloprost Drugs Report Years Considered
Figure 10. Global Iloprost Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Iloprost Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Iloprost Drugs Market Share by Region: 2022 VS 2029
Figure 13. Global Iloprost Drugs Market Share by Players in 2022
Figure 14. Global Top Iloprost Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iloprost Drugs as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Iloprost Drugs Revenue in 2022
Figure 16. North America Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Iloprost Drugs Market Share by Country (2018-2029)
Figure 18. United States Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Iloprost Drugs Market Share by Country (2018-2029)
Figure 22. Germany Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Iloprost Drugs Market Share by Region (2018-2029)
Figure 30. China Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Iloprost Drugs Market Share by Country (2018-2029)
Figure 38. Mexico Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Iloprost Drugs Market Share by Country (2018-2029)
Figure 42. Turkey Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Iloprost Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Actelion (J & J) Revenue Growth Rate in Iloprost Drugs Business (2018-2023)
Figure 45. Bayer AG Revenue Growth Rate in Iloprost Drugs Business (2018-2023)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 去勢抵抗性前立腺がん治療薬のグローバル市場展望 2023年-2029年：経口式、静脈注射式、その他
  • 進行性前立腺がん治療薬のグローバル市場展望 2023年-2029年：経口式、静脈注射式、その他
  • イロプロスト薬のグローバル市場展望 2023年-2029年：吸入型、静脈内型
  • イロプロストAPIの世界市場2023年：純度99%、純度99.5%
  • 高カリウム血症治療薬の世界市場2023年：パティロマー、シクロケイ酸ジルコニウムナトリウム
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8791 )"イロプロスト医薬品の世界市場2023年：吸入式、静脈注射式" (英文：Global Iloprost Drugs Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。